The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R,3R,4S,5R)-5-[4-amino-5-(1-methylimidazol-4-yl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-[[2-(ethylamino)-7-quinolyl]oxymethyl]-4-fluoro-tetrahydrofuran-3-ol ID: ALA5094610
PubChem CID: 166632188
Max Phase: Preclinical
Molecular Formula: C26H27FN8O3
Molecular Weight: 518.55
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCNc1ccc2ccc(OC[C@H]3O[C@@H](n4cc(-c5cn(C)cn5)c5c(N)ncnc54)[C@@H](F)[C@@H]3O)cc2n1
Standard InChI: InChI=1S/C26H27FN8O3/c1-3-29-20-7-5-14-4-6-15(8-17(14)33-20)37-11-19-23(36)22(27)26(38-19)35-9-16(18-10-34(2)13-32-18)21-24(28)30-12-31-25(21)35/h4-10,12-13,19,22-23,26,36H,3,11H2,1-2H3,(H,29,33)(H2,28,30,31)/t19-,22+,23-,26-/m1/s1
Standard InChI Key: LUOQYHYFHBUMIB-XQZLXVFMSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
-4.1722 1.0947 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.4576 1.5070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7458 1.0951 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.7458 0.2699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4559 -0.1418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1722 0.2662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2837 -0.9443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1348 -0.2780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4672 -1.0285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8829 -0.1439 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3422 -0.0656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0483 0.6999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2292 0.6570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0169 -0.1351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7048 -0.5818 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4585 1.4105 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.3509 1.2372 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7756 -0.3475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3558 0.2326 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1484 0.0202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7288 0.6004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5188 0.3879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7313 -0.4049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1551 -0.9833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3617 -0.7756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0978 0.9661 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8909 0.7538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1040 -0.0344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5275 -0.6180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4711 1.3341 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2587 2.1266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8390 2.7069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8639 -1.5245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7356 -2.3346 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.4664 -2.7069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0463 -2.1270 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.6739 -1.3962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.8390 -2.3394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
5 7 1 0
4 8 1 0
8 9 1 0
9 7 2 0
6 10 1 0
11 8 1 1
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 11 1 0
12 16 1 1
13 17 1 6
14 18 1 1
18 19 1 0
19 20 1 0
21 20 2 0
22 21 1 0
23 22 2 0
24 23 1 0
25 24 2 0
20 25 1 0
22 26 1 0
27 26 2 0
28 27 1 0
29 28 2 0
23 29 1 0
27 30 1 0
30 31 1 0
31 32 1 0
33 7 1 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 1 0
37 33 2 0
36 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 518.55Molecular Weight (Monoisotopic): 518.2190AlogP: 3.07#Rotatable Bonds: 7Polar Surface Area: 138.16Molecular Species: NEUTRALHBA: 11HBD: 3#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.71CX Basic pKa: 7.19CX LogP: 2.67CX LogD: 2.60Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.30Np Likeness Score: -0.21
References 1. (2021) Mettl3 modulators,